SUMMIT THERAPEUTICS INC (SMMT) Forecast, Price Target & Analyst Ratings

NASDAQ:SMMT • US86627T1088

Current stock price

16.58 USD
-0.68 (-3.94%)
At close:
16.91 USD
+0.33 (+1.99%)
Pre-Market:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SUMMIT THERAPEUTICS INC (SMMT).

Forecast Snapshot

Consensus Price Target

Price Target
$32.35
+ 95.11% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 29, 2026
Period
Q1 / 2026
EPS Estimate
-$0.15
Revenue Estimate
90.148K
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
79.13%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$32.35
Upside
+ 95.11%
From current price of $16.58 to mean target of $32.35, Based on 23 analyst forecasts
Low
$12.12
Median
$34.17
High
$44.10

Price Target Revisions

1 Month
-2.20%
3 Months
-2.20%

Price Target Summary

23 Wall Street analysts provided a forecast for the next 12 months for SMMT. The average price target is 32.35 USD. This implies a price increase of 95.11% is expected in the next year compared to the current price of 16.58.
The average price target has been revised downward by 2.2% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

SMMT Current Analyst RatingSMMT Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10

Analyst Ratings History

SMMT Historical Analyst RatingsSMMT Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20

Analyst Ratings Consensus

ChartMill Buy Consensus
79.13%
SMMT was analyzed by 23 analysts. The buy percentage consensus is at 79. So analysts seem to be have mildly positive about SMMT.
In the previous month the buy percentage consensus was at a similar level.
SMMT was analyzed by 23 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-16JefferiesDowngrade Buy -> Hold
2026-02-24HC Wainwright & Co.Maintains Buy -> Buy
2026-02-02HC Wainwright & Co.Reiterate Buy -> Buy
2026-01-30CitizensReiterate Market Outperform -> Market Outperform
2025-12-17BarclaysUpgrade Underweight -> Equal-Weight
2025-11-18Wolfe ResearchInitiate Peer Perform
2025-10-22GuggenheimReiterate Buy -> Buy
2025-10-21BarclaysMaintains Underweight -> Underweight
2025-10-21HC Wainwright & Co.Maintains Buy -> Buy
2025-10-20JMP SecuritiesReiterate Market Outperform -> Market Outperform
2025-10-20CitigroupMaintains Buy -> Buy
2025-09-17BarclaysInitiate Underweight
2025-09-16HC Wainwright & Co.Reiterate Buy -> Buy
2025-09-08Cantor FitzgeraldReiterate Overweight -> Overweight
2025-09-08HC Wainwright & Co.Reiterate Buy -> Buy
2025-09-04GuggenheimInitiate Buy
2025-09-03JMP SecuritiesReiterate Market Outperform -> Market Outperform
2025-09-02HC Wainwright & Co.Reiterate Buy -> Buy
2025-08-27HC Wainwright & Co.Maintains Buy -> Buy
2025-08-19JMP SecuritiesReiterate Market Outperform -> Market Outperform
2025-08-19Piper SandlerInitiate Neutral
2025-08-15HC Wainwright & Co.Reiterate Buy -> Buy
2025-08-12Evercore ISI GroupMaintains Outperform -> Outperform
2025-07-01UBSInitiate Buy
2025-07-01HC Wainwright & Co.Reiterate Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 29, 2026
Period
Q1 / 2026
EPS Estimate
-$0.15
Revenue Estimate
90.148K
Revenue Q2Q
N/A
EPS Q2Q
-64.03%
Number of Analysts
15

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%

Next Earnings Summary

SMMT is expected to report earnings on 4/29/2026. The consensus EPS estimate for the next earnings is -0.15 USD and the consensus revenue estimate is 90.15K USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
SMMT revenue by date.SMMT revenue by date.
860K
-98.49%		1.81M
110.47%		710K
-60.77%		N/A
-100.00%		9.709M104.92M
980.65%		961.06M
815.99%		2.679B
178.75%		4.69B
75.07%		6.986B
48.96%		8.984B
28.60%		10.492B
16.79%
EBITDA
YoY % growth
SMMT ebitda by date.SMMT ebitda by date.
-50.78M
-488.82%		-84.84M
-67.07%		-62.36M
26.50%		N/A
-41.98%		-224.001M
-138.21%		-504.927M
-139.41%		-841.336M
-66.63%		-864.796M
-2.79%		-906.136M
-4.78%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
SMMT ebit by date.SMMT ebit by date.
-52.33M
-563.51%		-86.19M
-64.70%		-63.62M
26.19%		N/A
-39.48%		-226.217M
-137.78%		-1.078B
-411.03%		-936.872M
13.11%		-950.524M
-1.46%		-308.37M
67.56%		1.549B
602.32%		3.155B
103.68%		4.477B
41.90%		5.668B
26.60%		6.33B
11.68%
Operating Margin
SMMT operating margin by date.SMMT operating margin by date.
-6,084.88%-4,761.88%-8,960.56%N/AN/AN/A-9,649.52%-905.95%-32.09%57.82%67.27%64.09%63.09%60.33%
EPS
YoY % growth
SMMT eps by date.SMMT eps by date.
-3.39N/AN/AN/A-0.31
-106.67%		-1.23
-161.29%		-1.02
-26.53%		-1.01
1.16%		-0.42
58.72%		1.10
362.78%		2.26
105.66%		3.36
48.70%		4.29
27.50%		4.24
-1.05%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.15
-64.03%		-0.14
-19.00%		-0.15
52.29%		-0.62
-112.09%		-0.33
-123.40%		-0.35
-142.86%		-0.36
-143.68%		-0.38
37.53%
Revenue
Q2Q % growth		90.148K127.5K5.163M24.48M
27,055.47%		26.724M28.968M
22,620.00%		31.212M
504.53%
EBITDA
Q2Q % growth		-179.472M
-168.57%		-175.867M
69.06%		-186.428M
-181.01%		-190.393M
-209.55%		N/AN/AN/AN/A
EBIT
Q2Q % growth		-196.238M
-193.54%		-207.283M
63.53%		-216.969M
-240.24%		-222.685M
-124.83%		-253.98M
-29.42%		-261.222M
-26.02%		-268.464M
-23.73%		-275.706M
-23.81%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

SMMT Yearly Revenue VS EstimatesSMMT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2026 2027 2028 2029 2030 2031 2032 2033 2B 4B 6B 8B 10B
SMMT Yearly EPS VS EstimatesSMMT Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 -2 4

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
14.06%
EPS Next 5 Year
36.80%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-56.36%
EBIT Next 5 Year
-41.47%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

SUMMIT THERAPEUTICS INC / SMMT Forecast FAQ

What do analysts expect the price target to be for SUMMIT THERAPEUTICS INC (SMMT)?

23 analysts have analysed SMMT and the average price target is 32.35 USD. This implies a price increase of 95.11% is expected in the next year compared to the current price of 16.58.

Can you provide the upcoming earnings date for SUMMIT THERAPEUTICS INC?

SUMMIT THERAPEUTICS INC (SMMT) will report earnings on 2026-04-29.

Can you provide the consensus estimates for SUMMIT THERAPEUTICS INC next earnings?

The consensus EPS estimate for the next earnings of SUMMIT THERAPEUTICS INC (SMMT) is -0.15 USD and the consensus revenue estimate is 90.15K USD.

Can you provide the analyst count for SUMMIT THERAPEUTICS INC stock?

The number of analysts covering SUMMIT THERAPEUTICS INC (SMMT) is 23.